A randomized, multicenter, active and placebo controlled parallel group study to evaluate the efficacy and safety of celecoxib (Ym177) 200 bid [twice daily] compared to loxoprofen 60 mg tid [three times daily] in patients with low back pain

Trial Profile

A randomized, multicenter, active and placebo controlled parallel group study to evaluate the efficacy and safety of celecoxib (Ym177) 200 bid [twice daily] compared to loxoprofen 60 mg tid [three times daily] in patients with low back pain

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2011

At a glance

  • Drugs Celecoxib; Loxoprofen
  • Indications Back pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2006 Status change
    • 14 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top